trial results on upadacitinib for the treatment of ra | roy fleischmann
Published 5 years ago • 1.3K plays • Length 6:19Download video MP4
Download video MP3
Similar videos
-
3:16
olokizumab: what makes it an effective and novel treatment for ra? | roy fleischmann
-
1:10
expert commentary: fenebrutinib in ra | roy fleischmann
-
1:14
new clinical trial looks at treatment option for rheumatoid arthritis
-
9:15
eular 2017 highlights | roy fleischmann
-
3:29
roy fleischmann, md: procedures for treating patients with rheumatoid arthritis
-
9:36
essential devices for hand arthritis: regain control of your life
-
16:11
top 5 foods to avoid for rheumatoid arthritis
-
13:09
5 signs of rheumatoid arthritis that you should not ignore
-
20:17
rheumatology author roy fleischmann: switching between upa and ada
-
4:13
dr roy fleischmann: ‘long-term safety of sarilumab in rheumatoid arthritis'
-
4:00
expert commentary: the select-psa-1 and select-psa-2 trials | alexis ogdie
-
2:23
mace vte across upadacitinib studies in ra patients: dr. jonathan kay
-
1:58
expert commentary: the finch 3 trial | roy fleischmann
-
32:35
rnl 2021 - future therapies in ra: dr. roy fleischmann
-
7:05
the ariaa trial of abatacept for subclinical arthritis | jürgen rech
-
2:55
expert commentary: safety and efficacy of tofacitinib in jia | sangeeta sule
-
15:23
rheumnow podcast – upadacitinib fda approved for ra
-
2:42
cobra trial 23-year follow-up analysis on mortality rates | elena nikiphorou
-
8:17
things aren't always what they seem: dmards & rheumatoid arthritis
-
3:22
do patients on upadacitinib need labs? dr. janet pope
-
7:20
researcher comment: the finch 1 trial
-
21:57
author interview: roy fleischmann